A Predictive nomogram for recurrence of carcinoma of the major salivary glands. JAMA Otolaryngol Head Neck Surg 2013 Jul;139(7):698-705.
High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg 2003 Jul;127(7):720-723.
The indications for elective treatment of the neck in cancer of major salivary glands. Cancer 1992 Feb;69(3):615-619.
Malignant tumors of major salivary gland origin. A matched pair analysis of the role of combined surgery and post-operative radiotherapy. Arch Otolaryngol Head Neck Surg 1990 Mar;116(3):290-293.
Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastasis, and overall survival: results of the Head and Neck Oncology Cooperative Group. Head Neck 2004 Aug;26(8):681-692.
Management of clinically negative cervical lymph nodes in oatients with malignant neoplasms of parotid gland. ORL J Otolaryngol Relat Spec 2001 May-Jun;63(3):123-126.
Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. RTOG Medical Research Council. Int J Radiat Oncol Biol Phys 1993 Sep 30;27(2):235-240.
Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral irradiation. Radiother Oncol 2016 Feb;118(2):286-292.
New developments in salivary gland pathology: clinically useful ancillary testing and new potentially targetable molecular alterations. Arch Pathol Lab Med 2017 Mar;141(3):381-395.
Perineural invasion in cancer: a review of the literature. Cancer 2009 Aug;115(15):3379-3391.
Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. J Natl Cancer Inst 2010 Jan;102(2):107-118.
Schwann cells induce cancer cell dispersion and invasion. J Clin Invest 2016 Apr;126(4):1538-1554.
Target-derived GFRalpha1 as an attractive guidance signal for developing sensory and sympathetic axons via activation of Cdk5. Neuron 2002 Oct;36(3):387-401.